Welcome to our dedicated page for BlackRock ESG Capital Allocation Term SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) brings together the fund’s regulatory disclosures as a non-diversified, closed-end management investment company. As a registered investment company, ECAT files documents with the U.S. Securities and Exchange Commission that describe its structure, investment objectives, governance, and material corporate actions.
Regulatory materials referenced in public announcements include tender offer statements on Schedule TO, proxy statements for annual meetings, and related exhibits. Tender offer documents outline the terms under which ECAT has offered to repurchase a portion of its outstanding common shares, including the percentage of shares subject to the offer and the method for determining the purchase price as a percentage of net asset value on a specified date.
Proxy statements and associated filings provide details on proposals submitted to shareholders, such as the election of trustees and a shareholder proposal to terminate BlackRock Advisors, LLC as investment adviser. These filings also form the basis for recommendations issued by proxy advisory firms Institutional Shareholder Services, Glass Lewis, and Egan-Jones, which are discussed in Business Wire releases.
Litigation involving ECAT’s voting bylaws, brought by Saba Capital Management, L.P., is also connected to the fund’s regulatory framework under the Investment Company Act. Court rulings described in public news highlight questions about how ECAT’s voting standards interact with statutory requirements for shareholder elections and board composition.
On Stock Titan, ECAT’s SEC filings are supplemented with AI-powered summaries that explain the key points of lengthy documents in plain language. Real-time updates from the SEC’s EDGAR system allow users to see new filings as they appear, while AI-generated highlights help identify important items in tender offer statements, proxy materials, and other disclosures. This structure enables investors to review ECAT’s regulatory history, advisory arrangements, and governance-related filings more efficiently.
Saba Capital Management, L.P., a director and 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/26/2025, the reporting person sold 56,976 shares of ECAT common stock at a price of $16 per share, marked with transaction code "S" for a sale. Following this transaction, the reporting person reported 26,735,799 shares of ECAT common stock beneficially owned with indirect ownership.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of the trust’s common stock. On 11/25/2025, the firm sold 49,669 ECAT common shares at a price of $15.8 per share, using transaction code "S" for a sale. After this transaction, Saba Capital Management, L.P. reported beneficial ownership of 26,792,775 ECAT common shares, held indirectly.
Saba Capital Management and its affiliates have significantly increased their stake in BlackRock ESG Capital Allocation Term Trust (ECAT). The amended Schedule 13D/A (Amendment No. 25) reports that Saba Capital, Saba Capital Management GP, LLC, and Boaz R. Weinstein collectively beneficially own 26,842,444 common shares, representing 27.02% of ECAT’s outstanding common stock, based on 99,345,793 shares outstanding as of 6/30/25.
The filing states that approximately $399,024,176 was paid to acquire the ECAT common shares, using investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All reported shares are held with shared voting and shared dispositive power, and the positions are owned by funds and accounts advised by Saba Capital, which are entitled to dividends and sale proceeds.
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner. On 11/24/2025, the reporting person executed a sale of 10,891 shares of common stock at a price of $15.65 per share, coded as an "S" transaction. After this sale, the reporting person reported 26,842,444 shares beneficially owned in an indirect capacity. The filing was made on Form 4 by a single reporting person and reflects a routine update to their equity holdings.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/19/2025, Saba disposed of 9,750 shares of ECAT common stock in an open-market sale at a price of $15.64 per share. After this transaction, Saba reported beneficial ownership of 26,853,335 ECAT shares, held indirectly. This filing is a routine disclosure of insider trading activity required for large shareholders.
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner on a Form 4. On 11/17/2025, the reporting person executed a sale of 44,604 shares of common stock at a price of $15.85 per share. After this transaction, the reporting person reported 26,863,085 shares of ECAT common stock beneficially owned in an indirect capacity. The filing reflects a routine update to the insider’s reported holdings and confirms the relationship as a 10% owner of the trust.
Saba Capital Management, L.P., a reporting person associated with BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market sales of the trust’s common stock on a Form 4. On 11/13/2025, it sold 62,082 shares at $16.45 per share, and on 11/14/2025 it sold 90,456 shares at $16.30 per share. After these transactions, the reporting person indirectly beneficially owned 26,907,689 common shares of ECAT.
BlackRock ESG Capital Allocation Term Trust (ECAT): A Form 4 shows a 10% owner reported open-market sales. Saba Capital Management, L.P. executed two sales of ECAT common stock: 17,653 shares at $16.28 on 11/10/2025 and 39,740 shares at $16.39 on 11/11/2025. Following these transactions, the reporting person beneficially owns 27,060,227 shares, held indirectly.
Saba Capital Management, L.P. filed a Form 4 for BlackRock ESG Capital Allocation Term Trust (ECAT), reporting an open-market sale of 57,053 common shares at $16.10 per share on 11/06/2025.
After this transaction, the filer reported 27,117,620 shares beneficially owned on an indirect basis. The filing was made by one reporting person.
BlackRock ESG Capital Allocation Term Trust (ECAT): Saba Capital Management, L.P., a 10% owner, reported open‑market sales of ECAT common stock. On November 4, 2025, it sold 3,600 shares at $16.30, and on November 5, 2025, it sold 49,369 shares at $16.30. Following the November 5 transaction, Saba reported 27,174,673 shares beneficially owned on an indirect basis.
FAQ
What is the current stock price of BlackRock ESG Capital Allocation Term (ECAT)?
What is the market cap of BlackRock ESG Capital Allocation Term (ECAT)?
